Kate Haviland, Chief Operating Officer at Blueprint Medicines Corp (BPMC), sold 21,644 shares at $85.05 ($1.8M) on 2019-03-01, disclosed to the SEC on 2019-03-05.
Open-market sale of $1.8M BPMC by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |